SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Vion (formerly Oncorx) interesting play on Gene Therapy
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Oravetz who wrote (228)2/22/2001 3:10:32 AM
From: Dave  Read Replies (1) of 370
 
Mr. Kessman concluded, "With several notable milestones reached, we begin the year 2001 as a much stronger company, with a stable of three product technologies, all in some stage of clinical development, important collaborations with which to expand our knowledge base and cash resources of approximately $24.4 million, which based on our current initiatives will fund the company's development efforts through the first quarter of 2002."

Did he really say that they're currently scheduled for bankruptcy in just one year?

Dave
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News